A Wellness Journey – a Column by Lisa Marie Basile

October 10, 2018October 10, 2018

3 Reasons to Be Thankful for Your AS Experience

A Wellness Journey - a Column by Lisa Marie Basile, Columns

Following my ankylosing spondylitis (AS) diagnosis, I thought the world had ended. I felt awful. I knew I was doomed to get sicker, and I believed I’d have limited ... Read more

October 3, 2018October 1, 2018

A Wellness Journey: 5 Excellent YouTube Videos About AS

A Wellness Journey - a Column by Lisa Marie Basile, Columns

After my diagnosis of ankylosing spondylitis (AS), I realized didn’t know anyone else with the disease. I was feeling exceptionally lost and alone. I turned to YouTube for community and education, ... Read more

September 26, 2018September 24, 2018

Newly Diagnosed? 4 Things You Should Know

A Wellness Journey - a Column by Lisa Marie Basile, Columns

If you’re anything like me, your ankylosing spondylitis (AS) diagnosis may not have been the easiest thing in the world to reconcile. Being diagnosed with a lifelong, degenerative, chronic illness ... Read more

August 29, 2018August 24, 2018

A Wellness Journey: Self-care and Ankylosing Spondylitis

A Wellness Journey - a Column by Lisa Marie Basile, Columns

Life with ankylosing spondylitis is full of ups and downs influenced by good days and bad days, endless fatigue, doctor’s appointments, and the general trickiness of managing a chronic illness ... Read more

June 4, 2018June 4, 2018

Lupin Seeks EU Marketing Approval for YLB113, Etanercept Biosimilar, for Ankylosing Spondylitis

A Wellness Journey - a Column by Lisa Marie Basile, News

The European Medicines Agency has accepted for review Lupin‘s marketing authorization application for YLB113, a biosimilar of etanercept that is marketed by Amgen under the brand name Enbrel. YLB113’s application is for the treatment of ankylosing ... Read more

Pin It on Pinterest